Related Experiment Videos
Baseline inflammatory markers do not modulate the lipid response to weight loss
Marie-Pierre St-Onge1, Renee Desmond, Gary Hunter
1Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35294, USA. ms2554@columbia.edu
Metabolism: Clinical and Experimental
|April 30, 2008
Summary
Baseline inflammation did not alter lipid and insulin responses to weight loss. However, weight loss significantly improved inflammatory status and metabolic risk factors in overweight premenopausal women.
Area of Science:
- Metabolic Health
- Inflammation Research
- Nutritional Science
Background:
- Baseline inflammatory status may influence metabolic responses to interventions.
- Investigating the role of inflammatory markers like C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) is crucial.
Purpose of the Study:
- To determine if baseline inflammation affects lipid and insulin profiles after weight loss.
- To examine the relationship between inflammatory markers and metabolic risk factors in overweight women.
Main Methods:
- 190 overweight premenopausal women underwent a weight loss intervention.
- Assessed body composition, lipids, insulin sensitivity (Si), and inflammation markers at baseline and post-weight loss.
- Utilized mixed-model, repeated-measures analysis to evaluate changes over time.
Main Results:
- Weight loss significantly improved lipid profiles (reduced total cholesterol, LDL, triglycerides; increased HDL) and insulin sensitivity.
- Higher baseline CRP levels showed a trend towards higher triglycerides and lower Si.
- No significant interaction was found between baseline inflammation and time for metabolic outcomes.
Conclusions:
- Baseline inflammatory status did not significantly modify the lipid and insulin response to weight loss in this cohort.
- Weight loss demonstrated a positive impact on both inflammatory markers and chronic metabolic disease risk factors.
Related Concept Videos
01:38Inflammation
Overview
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...